Clinical Trial Update: PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating PANHPVAX, a new human papillomavirus vaccine, in healthy volunteers; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• PANHPVAX

Snippet

Sponsor: German Cancer Research Center | Conditions: HPV | EARLY_Phase 1 | Status: RECRUITING